Table 2.

Correlation analysis (Spearman r and P-values) between adjusted total (T-ABs) and CNS cell-specific ABs (ND-ABs, neurons; AD-ABs, astrocytes; OD-ABs, oligodendrocytes; ED-ABs, endothelial cells; and MD-Abs, myeloid cells) in subjects' CSF (ABs/ml CSF) and their clinical measures of CNS tissue destruction, disability, and severity.

		T-ABs	ND-ABs	AD-ABs	OD-ABs	ED-ABs	MD-ABs
COMRIS-CTD	Spearman r	−0.20	−0.02	−0.10	−0.13	−0.19	−0.08
	P-value	0.25	0.89	0.57	0.46	0.26	0.66
EDSS	Spearman r	−0.07	0.23	0.07	0.01	0.07	0.15
	P-value	0.69	0.19	0.70	0.97	0.68	0.38
CombiWISE	Spearman r	−0.11	0.25	0.07	0.02	0.00	0.13
	P-value	0.53	0.14	0.68	0.92	0.99	0.45
MS-DSS	Spearman r	−0.18	0.04	−0.08	−0.09	−0.13	−0.04
	P-value	0.29	0.84	0.64	0.63	0.44	0.82
CombiWISE slope	Spearman r	−0.29	0.05	−0.05	−0.08	−0.30	−0.08
	P-value	0.09	0.80	0.76	0.64	0.08	0.65